Page URL:

Dr Sophie Pryor

Dr Sophie Pryor was previously a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. She currently works as a Medical Writer for Abacus International, a global healthcare market access consultancy based in Oxfordshire. Previously she completed a Wellcome Trust-funded PhD in Developmental and Stem Cell Biology at University College London's Institute of Child Health. Her research was conducted in the laboratory of the Institute's Director Professor Andrew Copp, and focuses on the genetics and developmental basis of neural tube defects. Previously she studied Biology at the University of York, and went on to work as a DNA Analyst for the Forensic Science Service.

BioNews Comment articles written by Dr Sophie Pryor:
Page 1 of 1
Freeing us from our cells: avoiding inherited mitochondrial disease
8 October 2012 - by Dr Sophie Pryor
On 25 September 2012 the Progress Educational Trust held a debate on the issues surrounding new techniques to prevent the transmission of mitochondrial disease. The event was organised in partnership with City University London's science journalism course and was supported by the Wellcome Trust.... [Read More]

BioNews News articles written by Dr Sophie Pryor:
Page 1 of 3
23andMe's 'designer baby' tool patent draws attention
7 October 2013 - by Dr Sophie Pryor
A US genetics company has been awarded a patent that relates to a DNA analysis service that predicts a baby's traits on the basis of its parents' genes.... [Read More]
'Mini-brains' grown from stem cells
2 September 2013 - by Dr Sophie Pryor
Human stem cells have been used to grow miniature brains, 'organoids' that are just millimetres across and at an equivalent developmental stage as in a nine-week-old fetus... [Read More]
NICE approves test for genetic markers of breast cancer
12 August 2013 - by Dr Sophie Pryor
A new diagnostic test that detects whether breast cancer has spread has been recommended for use in NHS practice by the National Institute for Health and Care Excellence (NICE)... [Read More]
HFEA launches public consultation on mitochondrial replacement techniques
17 September 2012 - by Dr Sophie Pryor
The UK's Human Fertilisation and Embryology Authority (HFEA) has launched a public consultation on the social and ethical impact of new methods that could prevent the transmission of some incurable mitochondrial diseases.... [Read More]
Protection against dementia may run in families
20 August 2012 - by Dr Sophie Pryor
Families with higher levels of a protein linked to inflammation may be at a reduced risk of dementia.... [Read More]
Amniotic fluid could provide alternative to embryonic stem cells
9 July 2012 - by Dr Sophie Pryor
Stem cells taken from amniotic fluid can be reprogrammed into a more versatile state similar to embryonic stem cells (ES cells) without the introduction of extra genes, UK scientists have found. The discovery offers hope that these cells could be banked for therapeutic use, research and drug screening... [Read More]
Florida doctor suspended following death of patient after unlicensed stem cell treatment
19 March 2012 - by Dr Sophie Pryor
A cardiologist in Bonita Springs, Florida, USA, has had his medical licence suspended after allegedly performing an illegal stem cell treatment on a patient who died during the procedure... [Read More]
Artificial testicle research given go-ahead
31 January 2012 - by Dr Sophie Pryor
The development of world's first artificial testicle for production of human sperm has been given the go ahead... [Read More]
Mouse fetal stem cells mend mum's broken heart
28 November 2011 - by Dr Sophie Pryor
Mouse fetal stem cells can travel from the placenta to heal their mother's damaged heart, US scientists have found. The discovery may explain why some women who suffer heart failure during or shortly after pregnancy recover faster, and offers hope for new treatment methods using human fetal stem cells... [Read More]
Stem cell trial for eye diseases begins
18 July 2011 - by Dr Sophie Pryor
Doctors in the USA have begun treating patients in two clinical trials for degenerative eye diseases. The studies at the Jules Stein Eye Institute at the University of California, Los Angeles (UCLA), will test whether specialised eye cells, which have been produced from human embryonic stem cells (hESCs), can be used to treat dry age-related macular degeneration (dry AMD) and Stargardt's macular dystrophy.... [Read More]